2.8.4 Idarucizumab

Idarucizumab
Idarucizumab 2.5g/50ml solution for infusion vials

On formulary for the treatment of:

Therapeutic Area Condition
Cardiovascular system Atrial fibrillation
Cardiovascular system Venous thromboembolism
Cardiovascular system Pulmonary embolism